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Cognitive functione that acts within the hypothalamus to suppress food intake and decrease body
adiposity, but it is increasingly clear that the hypothalamus is not the only site of leptin action, nor food
intake the only biological effect of leptin. Instead, leptin is a pleiotropic hormone that impinges on many
brain areas, and in doing so alters food intake, motivation, learning, memory, cognitive function,
neuroprotection, reproduction, growth, metabolism, energy expenditure, and more. This diversity of
function also means that a dysregulation of leptin secretion and signaling can have far reaching effects. To
date research on leptin signaling has focused primarily on the hypothalamus, and the result is a relative lack
of information regarding the impact of leptin signaling and leptin resistance in non-hypothalamic areas,
despite a growing literature implicating leptin in the regulation of neuronal structure and function in the
hippocampus, cortex and other brain areas associated with cognition.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The discovery of the protein hormone leptin ushered in an era in
which a variety of neural circuits, both within and outside the
hypothalamus, have been implicated in the regulation of food intake.
Like many hormones, the initial description of leptin as a regulator of
food intake and body adiposity focused the study of leptin biology, but
it is now clear that leptin does not produce a singular effect (i.e, a
reduction in food intake). This review will highlight the pleiotropic
effects of leptin on the brain, ﬁrst reviewing the role of hypothalamic
leptin signaling in the regulation of energy homeostasis, and then
moving to more recent data implicating leptin signaling in reward,
motivation, learning and memory and neuroprotection. These latter
effects appear to reﬂect leptin action in areas outside the hypotha-
lamus, and indicate that leptinmay have effects unrelated to its role as
a signal of body adiposity.
2. Leptin as an adiposity signal that acts in the hypothalamus
In both humans and animals, physiological mechanisms monitor
body adipose mass and react to changes in energy balance by altering
ingestive behavior and energy expenditure to buffer against drastic
changes in body adiposity and restore body weight and adiposity once
the nutritional challenge dissipates [1–3]. The protein hormone leptin
represents an afferent signal within this homeostatic mechanism,
with leptin being produced and secreted by adipocytes via mechan-
isms that are sensitive to both the chronic level of body adipose mass
as well as current metabolic status [4–7]. Of the brain areas mediatingll rights reserved.leptin action, the hypothalamic arcuate nucleus (ARC) is most closely
associated with leptin's effects on energy homeostasis (Fig. 1). The
ARC contains at least two populations of leptin-sensitive neurons. The
ﬁrst population contains the potent orexigenic peptides Neuropeptide
Y (NPY) and Agouti-Related Protein (AgRP). Central injection of either
NPY or AgRP leads to a profound increase in food intake, and acute
ablation of the NPY/AgRP neurons in adult animals leads to signiﬁcant
hypophagia and weight loss [8,9]. Thus NPY/AgRP neurons represent
important drivers of food intake, and leptin's action to suppress food
intake is mediated, at least in part, by its ability to inhibit these
neurons. Adjacent to NPY/AgRP neurons are a population of neurons
containing proopiomelanocortin (POMC) and cocaine and ampheta-
mine regulated transcript (CART). POMC is a large precursor protein
which is processed into a variety of smaller products, notably alpha-
melanocyte stimulating hormone (α-MSH). Central injection of
α-MSH or its stable analog Melanotan II (MTII) produces a marked
suppression of food intake, while genetic deletion of POMC results in
an obese phenotype [10,11]. Selective deletion of leptin receptors
within POMC neurons also results in an obese phenotype [12],
although the effect is much less robust than loss of POMC or deletion
of leptin receptors in all neurons. Thus POMC neurons exert a tonic
inhibitory inﬂuence on food intake, and leptin's action to suppress
food intake is at least partly mediated by an inhibition of POMC
neurons. A model has therefore emerged in which these two
populations of neurons exert opposing effects on feeding behavior
and energy metabolism, and simultaneously respond in an opposing
fashion to leptin.
The mechanism by which leptin regulates these neurons involves
changes in both gene expression and acute membrane activity
[13–15]. These observations suggest that leptin engages multiple
signaling pathways to impact neuronal function, and recent data
Fig. 1. Leptin sensitive brain areas in the regulation of energy homeostasis and
cognition. Leptin-dependent regulation of energy homeostasis is mediated by a
complex interaction of brain areas which contribute to leptin's suppression of feeding
behavior and stimulation of energy expenditure. Contrastingly, relatively little is known
about leptin's potential role in the regulation of cognition, but there is clear evidence for
a direct effect of leptin within areas of the cortex and hippocampus. It remains unclear
whether an interaction exists between those areas inﬂuencing energy homeostasis and
those inﬂuencing cognition, but the existence of well established neuroanatomical
connections indicate that such interactions are likely.
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cytokine receptor traditionally proposed to signal through the Janus
Kinase - Signal Transducer and Activator of Transcription (Jak-Stat)
pathway. Jak-Stat signaling is critical for leptin action on ARC neurons;
leptin induces Stat3 activation in both POMC and NPY neurons [17–19]
and loss of leptin's ability to activate Stat3 leads to obesity [20,21].
However, leptin also engages other intracellular pathways, including
ERK, PI3K and cAMP/PDE3B [22,23]. Of these, PI3K signaling has
received the most attention, as loss of PI3K signaling attenuates
leptin-induced inhibition of food intake, regulation of neuropeptide
expression, and stimulation of sympathetic nervous system activity
[22,24,25].
It should also be noted that these arcuate neurons respond to a
variety of signals in addition to leptin. Insulin also acts in the brain to
suppress NPY neurons and stimulate POMC neurons [26,27]. Direct
brain insulin injections suppress food intake, while selective deletion
of brain insulin receptor leads to obesity [28,29]. Thus insulin and
leptin have overlapping physiological effects, and this overlap is
mimicked by a degree of overlap in the intracellular signaling
pathways they regulate, although this regulation and interaction
appears to be highly complex. In addition to leptin and insulin these
neuronal populations also detect and respond to a variety of
additional nutrient signals, including hormonal signals such at ghrelin
and PYY [30,31], as well as fuels such as glucose, fatty acids and amino
acids [32–36].
While the arcuate nucleus has received the most attention as a site
mediating leptin's regulation of food intake, leptin appears to also act
in additional brain areas both within and outside the hypothalamus.
Recent work indicates that leptin activates at least one population of
neurons (SF-1 containing neurons) within the ventromedial nucleus
(VMN), and that speciﬁc deletion of leptin receptor in SF-1 neurons
increases food intake and body adiposity [37,38]. These data are
consistent with previous work demonstrating effects of exogenous
leptin on VMN neurons and reductions in food intake in response to
local VMH leptin injection [39,40], although the latter studies are
complicated by the close anatomical proximity of the VMN to the ARC.
There is also strong evidence that leptin suppresses food intake by
acting directly in areas of the caudal brainstem, in particular a
population of neurons within the nucleus of the solitary tract (NTS).
The NTS is classically associated with satiety and meal termination,and local injections of leptin into the brainstem produce reductions in
food intake that are similar in magnitude to injections into the
forebrain [41,42].
Lastly, it should it should also be recognized that the suppression of
food intake is only one component of leptin's overall effect on energy
homeostasis. In essence, the primary effect of brain leptin signaling
could be viewed as a reduction in body adiposity, with the suppression
of food intake (energy intake) being one component in an array of
physiological changes that collectively lead to reduced body adiposity
[43,44]. One example is the acute effect of leptin on sympathetic
outﬂow and energy expenditure. Relatively early on in the study of
leptin it was recognized that the reduction in body weight induced by
leptin involved more than changes in food intake [45], with leptin-
deﬁcient animals exhibiting increased energy efﬁciency such that
excess adiposity occurs even when hyperphagia is prevented [46].
These observations were extended when it was clearly described that
leptin increases energy expenditure and fat oxidation [47–49], at least
in part via an activation of the sympathetic nervous system [50,51],
and a resultant activation of brown adipose tissue (BAT) [52–54],
although leptin decreases body adiposity and increases energy
expenditure even in the absence of BAT-derived UCP1 [55]. These
observations are consistent with leptin regulating sympathetic out-
ﬂow and metabolism in other tissues, particularly skeletal muscle and
adipose tissue [49,51,54,56,57].
In addition to anactivationof the sympathetic nervous system, leptin
also regulates energy homeostasis via effects on neuroendocrine
hormone secretion [58], particularly the secretion of thyroid hormone,
gonadotropins, growth hormone, and ACTH. Leptin acts locally in the
hypothalamus to stimulate TRHneurons and TRH expression [59,60,61],
indicating that leptin regulation ofmetabolic rate includes a stimulatory
effect on the thyroid axis [62]. Although somewhat less direct, leptin
also alters energybalanceby regulating reproduction.Decreases in body
adiposity and periods of negative energy balance are associated with
impaired reproductive function in a variety of species [63], and this
effect is principally mediated by an inhibition of hypothalamic
gonadotropin releasing hormone (GnRH) secretion [64–66]. By acting
in the hypothalamus, leptin hastens the onset of puberty in mice [67–
69] and improves reproductive function in settings of negative energy
balance or leptin deﬁciency [70–72]. Likewise, leptin acts directlywithin
the brain to stimulate gonadotropin secretion [73–75], possibly via the
inhibition of NPY neurons [76–78]. Leptin deﬁcient humans exhibit
impaired reproduction and a failure to attain puberty, and this deﬁcit is
fully reversed by leptin replacement [79].
When taken together, these data provide a model for the neural
basis of leptin-dependent regulation of energy homeostasis. The
traditional view is thus one in which leptin, acting as an adiposity
signal, regulates a deﬁned populations of neurons in the hypothala-
mus to alter food intake and other components of energy homeostasis.
While an abundant literature supports the core of this model, it is also
apparent that leptin has a more diverse effect on the brain, with
implications not only on the regulation of food intake, but on brain
areas and neural systems that might be independent of the regulation
of energy homeostasis.
3. Leptin and food intake: reward and motivation
It is well recognized that nutritional status inﬂuences motivated
behavior. For instance, food deprivation increases motivation to attain
rewarding stimuli, including food, drugs of abuse, and electrical
stimulation of speciﬁc brain areas [80–82]. These observations
collectively demonstrate that negative energy balance enhances the
desire for rewarding stimuli. Interestingly, leptin attenuates the effects
of negative energy balance in these models [83–85], indicating that
leptin does not simply act in the brain to reduce the consumption of
food, but that it also acts more generally to reduce the motivation to
acquire rewards. Although areas of the hypothalamus (i.e. lateral
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hypothalamus are also involved. The mesolimbic dopamine system is
critical for the motivation to obtain pleasurable stimuli [86,87].
Dopaminergic projections from the ventral tegmental area to the
nucleus accumbens are particularly important, as manipulation of this
dopamine system powerfully inﬂuences instrumental performance
for and consumption of drugs or food [88–90]. Leptin directly
impinges on this system, acting in the VTA to suppress food intake
and modulate dopamine neurons [91–93], and also may indirectly
inﬂuence this system via effects in the hypothalamus. Thus leptin-
dependent suppression of food intake involves brain areas associated
with the anticipation, memory or motivation, as supported by
available data indicating that leptin alters behaviors related to food
intake but independent of the actual consumption of food [83,94].
Lastly, brain imaging studies in leptin deﬁcient humans have
highlighted the profound effect that the absence of leptin has on the
brain, with leptin deﬁcient humans responding more strongly to food
cues (i.e., images of foods) than normal individuals [95], and leptin
treatment altering the neuronal response to food cues in a variety of
brain areas [96,97]. Collectively, these data provide a unique view of
the expanding role for leptin, and demonstrate that leptin exerts
signiﬁcant effects on food intake via mechanisms that occur prior to
and separate from the actual consumption of food, and that these
effects are mediated by brain areas that are distinct from the
hypothalamus.
4. Leptin as a signal promoting neuronal survival and cognition
Upon its discovery, leptin was heralded as a hormone acting in the
brain as a signal of body adipose mass. Yet in addition to regulating
food intake and bodyweight homeostasis, leptin also acts within brain
areas that are unrelated (at least directly) to an effect on energy
homeostasis. Within these brain areas leptin alters neuronal/synaptic
function and structure, and inﬂuences neuronal survival and pro-
liferation. The result of these effects appears to be an improvement in
learning, memory and other forms of cognition and a resistance to
insults which impair cognitive performance.
Perhaps the ﬁrst evidence for a role for leptin in cognition is the
recognition that leptin receptors are expressed widely throughout the
brain. Although leptin receptors, particularly the signaling form of the
receptor (Long form — LepRb) are densely expressed within medial
areas of the hypothalamus, leptin receptors are also expressed in
many brain areas, including regions associated with learning and
memory, such as various cortical regions and the hippocampus
[98–102]. Another clue to the role of leptin in the regulation of these
brains areas stems from the clear effects that both diet and obesity
have on cognitive function. Variations in caloric intake or diet
composition can produce changes in gene expression within areas of
the hippocampus and cortex [103], indicating that these brain areas
are not insulated from variations in nutritional or metabolic status.
Similarly, it is increasingly apparent that alterations in nutritional
status can alter cognitive function, and in particular that settings of
obesity are associated with decreases in cognitive function [104].
Based on these and other observations, the key question therefore is
whether variations in leptin signaling contribute to changes to
metabolic or nutritionally induced alterations in neuronal or cognitive
function within areas outside the hypothalamus.
4.1. Effects on neuronal/synaptic function
Within these non-hypothalamic areas, leptin acts in part by
directly regulating neural function, including local effects at the
synapse [105]. In rodent models of genetic leptin or leptin receptor
deﬁciency, hippocampal neurons (CA1) exhibit impaired develop-
ment of long term potentiation (LTP) and depression (LTD), and an
associated reduction in CaMK II activity [106]. Consistent with thisobservation, leptin treatment of hippocampal neurons stimulates
CaMK II phosphorylation and facilitates the development of LTP [107].
These changes in LTP and LTD are inﬂuenced by leptin dependent
regulation of NMDA receptor function [108,109], as leptin enhances
NMDA-induced increases in intracellular calcium levels and facilitates
NMDA receptor-mediated synaptic transmission [108]. Leptin treat-
ment in neonatal animals altered the expression of NR1, NR2B,
synapsin 2A and synaptophysin in the hippocampus [110]. In addition
to altering NMDA receptors, there is also evidence that leptin regulates
the function of large-conductance, calcium activated K+ channels
(BK channels) [111,112]. Lastly, these effects of leptin are not limited to
hippocampal neurons, as leptin receptors are expressed in cerebellar
neurons at the both the somatic plasma membrane and the synapse,
and treatment of these neurons with leptin facilitated NR2B NMDA
receptor mediated calcium inﬂux [113].
Just as leptin regulates hypothalamic neurons via a variety of
signaling pathways, evidence suggests that leptin uses multiple
signaling pathways to regulate non-hypothalamic neurons. For leptin
dependent effects on synaptic function and activity, a large abundance
of data implicates leptin-dependent activation of phosphotidylinositol
3-kinase (PI3K) signaling. PI3K is implicated in leptin-dependent
regulation of LTP and LTD, NMDA receptors, and actin cytoskeleton
dependent clustering of BK channels [108,109,111,112]. Yet other
signaling systems are also implicated, including leptin activation of
MAPK and Src signaling [108,113]. Taken together, the above data
indicates that leptin directly regulates the signaling and synaptic
activity of neurons within the hippocampus, cortex and cerebellum. It
is thus highly likely that these signaling effects contribute to the
cognitive and behavioral effects of leptin that will be discussed below.
4.2. Effects on neuronal structure and plasticity
In addition to direct effects on neuronal/synaptic function, leptin
also appears to inﬂuence neurons by altering their structure and
plasticity. Initial evidence for this effect stemmed from the observa-
tion that rodent models of leptin deﬁciency exhibit smaller brains,
that these alterations in brain development are evident in utero, and
that leptin replacement in these models serves to increase brain size,
protein and DNA [114–117]. More recent studies provide evidence for
neuroproliferative effects within the fetal cortex, and indicate that
leptin is associated with a maintenance and differentiation of neural
stem cells, glial-restricted progenitor cells and/or neuronal lineage
cells [118]. Interestingly, similar observations have been made in
humans, where fasting plasma leptin levels in normal humans are
correlated with grey matter volume in several brain areas [119], and
leptin replacement in leptin deﬁcient humans leads to gross changes
in brain structure, particularly an increase in grey matter volume in
discrete areas [120]. These very provocative observations thus provide
strong evidence that leptin, and particularly the absence of leptin, has
fundamental effects on brain structure.
In addition to these general effects of leptin, there have been more
speciﬁc observations of leptin dependent changes in neuronal
structure in a variety of brain areas, including the hypothalamus.
Leptin deﬁciency appears to reduce the density of axonal projections
from leptin sensitive neurons, and this structural defect can be
restored by leptin treatment during a critical period of neonatal life
[121]. Consistent with this observation, leptin acts on arcuate nucleus
explants to promote neurite outgrowth [121]. Similar observations
have also been made within areas of the hippocampus, cortex and
cerebellum. Leptin was shown to act in cerebellar neurons to promote
neurite outgrowth and increase the complexity of the neurite arbor
[122], in hippocampal cells to enhance the motility and density of
dendritic ﬁlopodia [123], and in cortical neurons to stimulate growth
cone morphogenesis [124]. Lastly, there is also evidence in the
hypothalamus that leptin inﬂuences the number of both inhibitory
and stimulatory synaptic inputs onto neurons within the arcuate
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tion of synaptic input onto feeding related neurons, and leptin
treatment induces a relatively rapid reorganization of the synaptic
input to these ARC neurons [125]. In summary, these data collectively
support a model in which leptin acts to inﬂuence neuronal structure
and plasticity. As such, these changes provide an additional means by
which leptin might regulate neuronal function.
4.3. Effects on neuronal survival and proliferation
It has long been known that various growth factors act on neurons
to protect against neurodegeneration and cell death [126], and a
rather large literature has accumulated speciﬁcally implicating leptin
as a neuroprotective signal [127]. Within a variety of non-neural cells,
including cancer cells, leptin has been show to inhibit apoptotic cell
death [128–132]. In neurons in vitro, leptin appears to attenuate cell
death induced by the removal of serum or neurotrophines [133,134],
to improve cell survival in models of ischemic stroke [135,136], to
protect against glutamatergic excitotoxicity [133,137], to protect
against oxidative stress [133], and to promote the proliferation of
hippocampal progenitor cells [138]. These in vitro effects of leptin
are replicated by in vivo experiments demonstrating that leptin atte-
nuates the loss of dopamine neurons in a chemically inducedmodel of
Parkinson's disease [139], that leptin deﬁcient mice are more sensitive
to middle cerebral artery occlusion (MCAO) but that leptin treatment
decreases infarct volume and animal recovery following MCAO
[135,140], and that leptin reduces symptoms of chemically induced
epileptic seizures [141]. These effects of leptin appear to stem from
leptin's activation of intracellular signaling pathways associated with
growth factor signaling, including the activation of Stat3, PI3K/Akt
and ERK/MAPK [133–136,138,139,141]. Interestingly some evidence
also implicates an effect of leptin on the NF-KappaB/c-Rel signaling
pathway, as the ability of leptin to improve function following MCAO
was attenuated in c-Rel deﬁcient mice, and leptin stimulated the
antiapoptotic Bcl-xl in cortical neurons via a c-Rel dependent
mechanism [140]. Taken together, these data provide compelling
support for leptin as a neuroprotective signal, although the physio-
logical implications of this relationship are not fully clear. Are
physiological increases (or decreases) in leptin relevant to neuronal
health? Are these effects in any way related to leptin's role as a
nutritional signal? Additional work is clearly required to test whether
leptin's neuroprotective actions have any role in neurodegenerative
processes, particularly those related to nutrition and metabolism.
4.4. Effects on cognition and behavior
The above observations provide strong support for a role for leptin
in a variety of brain areas and signaling systems that appear, at least on
the surface, to be unrelated to its role in energy homeostasis. In
addition, these molecular and cellular examples for leptin-dependent
effects on synaptic function, neuronal structure, and neuroprotection
also provide a mechanistic basis for the remarkable observation that
leptin acts within the brain to support and promote cognitive
function. The relationship between leptin and cognitive function
exists on multiple levels. First, correlational evidence provides a link
between altered, particularly reduced, circulating leptin levels and
impaired cognition in humans [142–144], with examples including a
correlation between high leptin and improved cognition in the elderly
and an association between low leptin levels and impaired learning
and memory in HIV infected men. Secondly, genetic models of leptin
suggest that leptin deﬁciency impairs cognitive performance
[106,145–147]. The most provocative of these is the human example,
where a leptin deﬁcient individual with reduced cognitive perfor-
mance at baseline exhibited a marked improvement in neurocognitive
tests following leptin treatment [145]. Lastly, there is also direct
evidence for an effect of leptin treatment to improve cognitiveperformance in rodents [107]. These experiments particularly impli-
cate the hippocampus, as local injections of leptin into the hippo-
campus improved memory retention [148], although at least one
experiment has failed to detect an effect of hippocampal leptin on
spatial memory [149].
While these observations provide a direct link between leptin and
cognition, it is currently unclear whether these behavioral effects of
leptin are mediated by discrete brain regions (hippocampus vs
cortex), or whether these cognitive changes are mediated by any or
all of the diverse effects of leptin on synaptic function, neuronal
structure and plasticity, and neuroprotection. Nevertheless, these
observations provide an exciting new direction for leptin research, and
clearly indicate that leptin is much more than an adiposity signal that
acts within the hypothalamus to regulate food intake.
5. Implications for leptin resistance
Shortly after the discovery of leptin, it was recognized that leptin
deﬁciency was not a common cause of obesity. Instead, most obese
individuals exhibit high circulating leptin levels coincident with
ongoing hyperphagia [5]. Obese humans and animals are also
relatively unresponsive to exogenously administered leptin, and this
syndrome of reduced sensitivity to endogenous and exogenous leptin
has been termed leptin resistance [150]. Leptin resistance appears to
occur on at least two fronts, with the ﬁrst being a reduced relative
transport of circulating leptin across the blood brain barrier [151], and
the second a reduction in intracellular signaling downstream of the
leptin receptor. The existence of leptin resistance, at least within the
hypothalamus, is thus well accepted, and considerable research effort
continues to focus on hypothalamic resistance, both to deﬁne the
cellular mechanisms underlying leptin resistance and to determine
the role of hypothalamic leptin resistance in the development of
obesity [152–155]. Yet absent within this discussion is the considera-
tion that leptin resistance within non-hypothalamic areas might also
occur, and that this resistance, by altering neuronal function within
brain areas such as the cortex and hippocampus, might also alter
behavior and cognition.
The study of leptin resistance has focused primarily on the failure
of exogenous leptin to reduce food intake and activate key signaling
molecules (Stat3) within neurons of the hypothalamic arcuate
nucleus. This ARC-speciﬁc leptin resistance is well described, and
occurs in response to high fat diets, age, pregnancy and lactation,
seasonal variations, and even chronic leptin exposure [153,156–161].
But does leptin resistance occur in brain areas besides the arcuate
nucleus? In addressing the question of region-speciﬁc leptin resis-
tance, Munzberg et al. [162] compared leptin-induced phosphoryla-
tion of Stat3 in a variety of brain areas in mice fed a high diet, while
Ladyman et al. [163] conducted a similar study in pregnant, leptin
resistant rats. These experiments detected a marked reduction of
leptin-dependent Stat3 phosphorylation in the ARC in leptin resistant
animals, but persistent leptin signaling within other brain areas both
within and outside the hypothalamus. The conclusion was therefore
that leptin resistance occurs speciﬁcally in the hypothalamic arcuate
nucleus, and to date few if any studies have followed up on these
observations by focusing on leptin resistance in non-hypothalamic
areas. However, it should be noted that these anatomical studies were
based solely on leptin activation of Stat3, and did not account for
changes in other signaling pathways. Yet the majority of studies
indicate that leptin-dependent changes in neuroprotection, prolifera-
tion, synaptic function and structural plasticity are mediated by
pathways such as the PI3K/Akt pathway and ERK/MAPK signaling
[108,109,111–113,123,133–136,138,139,141]. Thus, it remains possible
that leptin signaling is altered within these brain areas, despite a
normal or persistent regulation of Stat3. Available evidence already
exists to suggest that leptin resistance may vary based on biological
endpoint. For instance, there is evidence that leptin-dependent effects
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suppression of food intake [164,165]. These data therefore provide
support for the hypothesis that leptin signaling and leptin resistance
vary across brain areas.
Although virtually no work has speciﬁcally tested whether leptin
resistance develops within brain areas associated with learning,
memory or other aspects of cognitive function, a collective considera-
tion of the work reviewed above provides a foundation for this
hypothesis. First, increasing age, obesity and metabolic dysfunction
each negatively impact these brain areas and lead to impaired
cognitive function. Second, leptin signaling, at least within the
hypothalamus, is impaired coincident with age, obesity and metabolic
dysfunction. Third, animals with genetically impaired leptin signaling
show defects in cognitive function. Fourth, exogenous leptin admi-
nistration improves cognitive function and protects neurons against
damage and degeneration, including an effect of leptin when directly
administered into the hippocampus. Taken together, these observa-
tions indicate that leptin signaling (or the loss thereof) in the cortex or
hippocampus is well positioned to contribute to age and/or diet-
associated declines in cognitive function. However, future studies
must be designed to clearly test whether and when leptin resistance
develops in these non-hypothalamic areas, and then to determine if
maintenance of leptin signaling ameliorates the effects of diet or age.
6. Conclusions
Leptin has received considerable attention as a nutritional signal
acting in the hypothalamus to suppress food intake. Yet leptin is a
pleiotropic hormone, impinging on a variety of brain areas to inﬂuence
satiety, motivation, learning, memory, cognitive function, reproduc-
tion, growth, metabolism, and additional effects not discussed here
[166–168]. This diversity of function indicates that the dysregulation
of leptin secretion and signaling that occurs in settings of both
undernutrition and obesity can have far reaching effects.While to date
research on leptin resistance has focused primarily on the hypotha-
lamus and emphasized obesity and diabetes, it is increasingly
apparent that leptin also acts within areas such as the cortex and
hippocampus to inﬂuence neuronal function and promote cognition.
As such, alterations in leptin signaling within these non-hypothalamic
brain areas may provide a unique mechanism linking obesity and
diabetes to impaired cognitive function.
References
[1] R.B. Harris, T.R. Kasser, R.J. Martin, Dynamics of recovery of body composition
after overfeeding, food restriction or starvation of mature female rats, J. Nutr. 116
(1986) 2536–2546.
[2] E.A. Sims, E. Danforth Jr., E.S. Horton, G.A. Bray, J.A. Glennon, L.B. Salans,
Endocrine and metabolic effects of experimental obesity in man, Recent Prog.
Horm. Res. 29 (1973) 457–496.
[3] E.A. Sims, R.F. Goldman, C.M. Gluck, E.S. Horton, P.C. Kelleher, D.W. Rowe,
Experimental obesity in man, Trans. Assoc. Am. Physicians 81 (1968) 153–170.
[4] L.A. Campﬁeld, F.J. Smith, Y. Guisez, R. Devos, P. Burn, Recombinant mouse OB
protein: evidence for a peripheral signal linking adiposity and central neural
networks, Science 269 (1995) 546–549.
[5] R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R.
Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, et al., Serum
immunoreactive-leptin concentrations in normal-weight and obese humans,
N. Engl. J. Med. 334 (1996) 292–295.
[6] J.L. Halaas, K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L.
Lallone, S.K. Burley, J.M. Friedman, Weight-reducing effects of the plasma protein
encoded by the obese gene, Science 269 (1995) 543–546.
[7] R.E. Ostlund, J.W. Yang, S. Klein, R. Gingerich, Relation between plasma leptin
concentration and body fat, gender, diet, age, and metabolic covariates, J. Clin.
Endocrinol. Metab. 81 (1996) 3909–3913.
[8] E. Gropp, M. Shanabrough, E. Borok, A.W. Xu, R. Janoschek, T. Buch, L. Plum, N.
Balthasar, B. Hampel, A. Waisman, G.S. Barsh, T.L. Horvath, J.C. Bruning, Agouti-
related peptide-expressing neurons are mandatory for feeding, Nat. Neurosci. 8
(2005) 1289–1291.
[9] S. Luquet, F.A. Perez, T.S. Hnasko, R.D. Palmiter, NPY/AgRP neurons are essential
for feeding in adult mice but can be ablated in neonates, Science 310 (2005)
683–685.
[10] H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant, A. Gruters, Severe early-onset obesity, adrenal insufﬁciency and red hair pigmentation caused by POMC
mutations in humans, Nat. Genet. 19 (1998) 155–157.
[11] L. Yaswen, N. Diehl, M.B. Brennan, U. Hochgeschwender, Obesity in the mouse
model of pro-opiomelanocortin deﬁciency responds to peripheral melanocortin,
Nat. Med. 5 (1999) 1066–1070.
[12] N. Balthasar, R. Coppari, J. McMinn, S.M. Liu, C.E. Lee, V. Tang, C.D. Kenny, R.A.
McGovern, S.C. Chua Jr., J.K. Elmquist, B.B. Lowell, Leptin receptor signaling in
POMC neurons is required for normal body weight homeostasis, Neuron 42
(2004) 983–991.
[13] M.A. Cowley, J.L. Smart, M. Rubinstein, M.G. Cerdan, S. Diano, T.L. Horvath, R.D.
Cone, M.J. Low, Leptin activates anorexigenic POMC neurons through a neural
network in the arcuate nucleus, Nature 411 (2001) 480–484.
[14] M.W. Schwartz, R.J. Seeley, S.C. Woods, D.S. Weigle, L.A. Campﬁeld, P. Burn, D.G.
Baskin, Leptin increases hypothalamic pro-opiomelanocortin mRNA expression
in the rostral arcuate nucleus, Diabetes 46 (1997) 2119–2123.
[15] D. Spanswick, M.A. Smith, V.E. Groppi, S.D. Logan, M.L. Ashford, Leptin inhibits
hypothalamic neurons by activation of ATP-sensitive potassium channels, Nature
390 (1997) 521–525.
[16] H. Munzberg, M.G. Myers Jr., Molecular and anatomical determinants of central
leptin resistance, Nat. Neurosci. 8 (2005) 566–570.
[17] C.F. Elias, C. Aschkenasi, C. Lee, J. Kelly, R.S. Ahima, C. Bjorbaek, J.S. Flier, C.B. Saper,
J.K. Elmquist, Leptin differentially regulates NPYand POMC neurons projecting to
the lateral hypothalamic area, Neuron 23 (1999) 775–786.
[18] M.L. Hakansson, B. Meister, Transcription factor STAT3 in leptin target neurons of
the rat hypothalamus, Neuroendocrinology 68 (1998) 420–427.
[19] H. Munzberg, L. Huo, E.A. Nillni, A.N. Hollenberg, C. Bjorbaek, Role of signal trans-
ducer and activator of transcription 3 in regulation of hypothalamic proopiome-
lanocortin gene expression by leptin, Endocrinology 144 (2003) 2121–2131.
[20] S.H. Bates, W.H. Stearns, T.A. Dundon, M. Schubert, A.W. Tso, Y. Wang, A.S. Banks,
H.J. Lavery, A.K. Haq, E. Maratos-Flier, B.G. Neel, M.W. Schwartz, M.G. Myers Jr.,
STAT3 signalling is required for leptin regulation of energy balance but not
reproduction, Nature 421 (2003) 856–859.
[21] A.W. Xu, L. Ste-Marie, C.B. Kaelin, G.S. Barsh, Inactivation of signal transducer and
activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes de-
creased pomc expression, mild obesity, and defects in compensatory refeeding,
Endocrinology 148 (2007) 72–80.
[22] K.D. Niswender, G.J. Morton, W.H. Stearns, C.J. Rhodes, M.G. Myers Jr., M.W.
Schwartz, Intracellular signalling. Key enzyme in leptin-induced anorexia,
Nature 413 (2001) 794–795.
[23] A.Z. Zhao, J.N. Huan, S. Gupta, R. Pal, A. Sahu, A phosphatidylinositol 3-kinase
phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on
feeding, Nat. Neurosci. 5 (2002) 727–728.
[24] C.D. Morrison, G.J. Morton, K.D. Niswender, R.W. Gelling, M.W. Schwartz, Leptin
inhibits hypothalamic Npy and Agrp gene expression via a mechanism that
requires phosphatidylinositol 3-OH-kinase signaling, Am. J. Physiol. Endocrinol.
Metab. 289 (2005) E1051–E1057.
[25] K. Rahmouni, W.G. Haynes, D.A. Morgan, A.L. Mark, Intracellular mechanisms
involved in leptin regulation of sympathetic outﬂow, Hypertension 41 (2003)
763–767.
[26] L. Plum, B.F. Belgardt, J.C. Bruning, Central insulin action in energy and glucose
homeostasis, J. Clin. Invest. 116 (2006) 1761–1766.
[27] S.C. Woods, R.J. Seeley, Insulin as an adiposity signal, Int. J. Obes. Relat. Metab.
Disord. 25 (Suppl. 5) (2001) S35–S38.
[28] J.C. Bruning, D. Gautam, D.J. Burks, J. Gillette, M. Schubert, P.C. Orban, R. Klein, W.
Krone, D. Muller-Wieland, C.R. Kahn, Role of brain insulin receptor in control of
body weight and reproduction, Science 289 (2000) 2122–2125.
[29] S.C. Woods, E.C. Lotter, L.D. McKay, D. Porte Jr., Chronic intracerebroventricular
infusion of insulin reduces food intake and body weight of baboons, Nature 282
(1979) 503–505.
[30] D. Kohno, H.Z. Gao, S. Muroya, S. Kikuyama, T. Yada, Ghrelin directly interacts
with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+
signaling via protein kinase A and N-type channel-dependent mechanisms and
cross-talk with leptin and orexin, Diabetes 52 (2003) 948–956.
[31] T. Riediger, C. Bothe, C. Becskei, T.A. Lutz, Peptide YY directly inhibits ghrelin-
activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos
expression, Neuroendocrinology 79 (2004) 317–326.
[32] D. Cota, K. Proulx, K.A. Smith, S.C. Kozma, G. Thomas, S.C. Woods, R.J. Seeley,
Hypothalamic mTOR signaling regulates food intake, Science 312 (2006) 927–930.
[33] B.E. Levin, Glucosensing neurons do more than just sense glucose, Int. J. Obes.
Relat. Metab. Disord. 25 (Suppl. 5) (2001) S68–S72.
[34] C.D. Morrison, X. Xi, C.L. White, J. Ye, R.J. Martin, Amino acids inhibit Agrp gene
expression via an mTOR-dependent mechanism, Am. J. Physiol. Endocrinol.
Metab. 293 (2007) E165–E171.
[35] S. Obici, Z. Feng, K. Morgan, D. Stein, G. Karkanias, L. Rossetti, Central adminis-
tration of oleic acid inhibits glucose production and food intake, Diabetes 51
(2002) 271–275.
[36] M. van den Top, D. Spanswick, Integration of metabolic stimuli in the
hypothalamic arcuate nucleus, Prog. Brain Res. 153 (2006) 141–154.
[37] H. Dhillon, J.M. Zigman, C. Ye, C.E. Lee, R.A. McGovern, V. Tang, C.D. Kenny, L.M.
Christiansen, R.D. White, E.A. Edelstein, R. Coppari, N. Balthasar, M.A. Cowley, S.
Chua Jr., J.K. Elmquist, B.B. Lowell, Leptin directly activates SF1 neurons in the
VMH, and this action by leptin is required for normal body-weight homeostasis,
Neuron 49 (2006) 191–203.
[38] N.C. Bingham, K.K. Anderson, A.L. Reuter, N.R. Stallings, K.L. Parker, Selective loss
of leptin receptors in the ventromedial hypothalamic nucleus results in increased
adiposity and a metabolic syndrome, Endocrinology 149 (2008) 2138–2148.
406 C.D. Morrison / Biochimica et Biophysica Acta 1792 (2009) 401–408[39] R.J. Jacob, J. Dziura, M.B. Medwick, P. Leone, S. Caprio, M. During, G.I. Shulman,
R.S. Sherwin, The effect of leptin is enhanced by microinjection into the
ventromedial hypothalamus, Diabetes 46 (1997) 150–152.
[40] J.K. Elmquist, R.S. Ahima, E. Maratos-Flier, J.S. Flier, C.B. Saper, Leptin activates
neurons in ventrobasal hypothalamus and brainstem, Endocrinology 138 (1997)
839–842.
[41] H.J.Grill, Distributedneural control of energybalance: contributions fromhindbrain
and hypothalamus, Obesity (Silver Spring) 14 (Suppl. 5) (2006) 216S–221S.
[42] H.J. Grill, M.W. Schwartz, J.M. Kaplan, J.S. Foxhall, J. Breininger, D.G. Baskin,
Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on
food intake, Endocrinology 143 (2002) 239–246.
[43] R.B. Harris, Leptin—much more than a satiety signal, Annu. Rev. Nutr. 20 (2000)
45–75.
[44] R.H. Unger, The physiology of cellular liporegulation, Annu. Rev. Physiol. 65
(2003) 333–347.
[45] S. Collins, C.M. Kuhn, A.E. Petro, A.G. Swick, B.A. Chrunyk, R.S. Surwit, Role of
leptin in fat regulation, Nature 380 (1996) 677.
[46] D.L. Coleman, Increased metabolic efﬁciency in obese mutant mice, Int. J. Obes. 9
(Suppl. 2) (1985) 69–73.
[47] J.J. Hwa, A.B. Fawzi, M.P. Graziano, L. Ghibaudi, P. Williams, M. Van Heek, H. Davis,
M. Rudinski, E. Sybertz, C.D. Strader, Leptin increases energy expenditure and
selectively promotes fat metabolism in ob/ob mice, Am. J. Physiol. 272 (1997)
R1204–R1209.
[48] T. Wang, D.L. Hartzell, B.S. Rose, W.P. Flatt, M.G. Hulsey, N.K. Menon, R.A. Makula,
C.A. Baile, Metabolic responses to intracerebroventricular leptin and restricted
feeding, Physiol. Behav. 65 (1999) 839–848.
[49] M. Shimabukuro, K. Koyama, G. Chen, M.Y. Wang, F. Trieu, Y. Lee, C.B. Newgard,
R.H. Unger, Direct antidiabetic effect of leptin through triglyceride depletion of
tissues, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4637–4641.
[50] J.C. Dunbar, Y. Hu, H. Lu, Intracerebroventricular leptin increases lumbar and
renal sympathetic nerve activity and blood pressure in normal rats, Diabetes 46
(1997) 2040–2043.
[51] W.G. Haynes, D.A. Morgan, S.A. Walsh, A.L. Mark, W.I. Sivitz, Receptor-mediated
regional sympathetic nerve activation by leptin, J. Clin. Invest. 100 (1997) 270–278.
[52] I. Cusin, K.E. Zakrzewska, O. Boss, P. Muzzin, J.P. Giacobino, D. Ricquier, B.
Jeanrenaud, F. Rohner-Jeanrenaud, Chronic central leptin infusion enhances
insulin-stimulated glucose metabolism and favors the expression of uncoupling
proteins, Diabetes 47 (1998) 1014–1019.
[53] P.J. Scarpace, M.Matheny, Leptin induction of UCP1 gene expression is dependent
on sympathetic innervation, Am. J. Physiol. 275 (1998) E259–E264.
[54] S.P. Commins, D.J. Marsh, S.A. Thomas, P.M. Watson, M.A. Padgett, R. Palmiter,
T.W. Gettys, Norepinephrine is required for leptin effects on gene expression in
brown and white adipose tissue, Endocrinology 140 (1999) 4772–4778.
[55] J. Ukropec, R.V. Anunciado, Y. Ravussin, L.P. Kozak, Leptin is required
for uncoupling protein-1-independent thermogenesis during cold stress,
Endocrinology 147 (2006) 2468–2480.
[56] Y. Minokoshi, Y.B. Kim, O.D. Peroni, L.G. Fryer, C. Muller, D. Carling, B.B. Kahn,
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein
kinase, Nature 415 (2002) 339–343.
[57] M. Rosenbaum, R. Goldsmith, D. Bloomﬁeld, A. Magnano, L. Weimer, S.
Heymsﬁeld, D. Gallagher, L. Mayer, E. Murphy, R.L. Leibel, Low-dose leptin
reverses skeletal muscle, autonomic, and neuroendocrine adaptations to
maintenance of reduced weight, J. Clin. Invest. 115 (2005) 3579–3586.
[58] R.S. Ahima, Leptin and the neuroendocrinology of fasting, Front. Horm. Res. 26
(2000) 42–56.
[59] G. Legradi, C.H. Emerson, R.S. Ahima, J.S. Flier, R.M. Lechan, Leptin prevents
fasting-induced suppression of prothyrotropin-releasing hormone messenger
ribonucleic acid in neurons of the hypothalamic paraventricular nucleus,
Endocrinology 138 (1997) 2569–2576.
[60] C. Fekete, J. Kelly, E. Mihaly, S. Sarkar, W.M. Rand, G. Legradi, C.H. Emerson, R.M.
Lechan, Neuropeptide Y has a central inhibitory action on the hypothalamic-
pituitary-thyroid axis, Endocrinology 142 (2001) 2606–2613.
[61] C. Fekete, G. Legradi, E. Mihaly, Q.H. Huang, J.B. Tatro, W.M. Rand, C.H. Emerson,
R.M. Lechan, alpha-Melanocyte-stimulating hormone is contained in nerve
terminals innervating thyrotropin-releasing hormone-synthesizing neurons in
the hypothalamic paraventricular nucleus and prevents fasting-induced sup-
pression of prothyrotropin-releasing hormone gene expression, J. Neurosci. 20
(2000) 1550–1558.
[62] R.M. Lechan, C. Fekete, The TRH neuron: a hypothalamic integrator of energy
metabolism, Prog. Brain Res. 153 (2006) 209–235.
[63] J.E. Schneider, Energy balance and reproduction, Physiol. Behav. 81 (2004)
289–317.
[64] F.H.Bronson, Food-restricted, prepubertal, female rats: rapid recoveryof luteinizing
hormone pulsingwith excess food, and full recovery of pubertal developmentwith
gonadotropin-releasing hormone, Endocrinology 118 (1986) 2483–2487.
[65] D.L. Foster, D.H. Olster, Effect of restricted nutrition on puberty in the lamb:
patterns of tonic luteinizing hormone (LH) secretion and competency of the LH
surge system, Endocrinology 116 (1985) 375–381.
[66] T.M. McShane, D.H. Keisler, Effects of dietary energy on ovarian function,
estrogen suppression of luteinizing hormone and follicle-stimulating hormone,
and competency of the gonadotropin surge, Biol. Reprod. 45 (1991) 486–492.
[67] F.F. Chehab, K. Mounzih, R. Lu, M.E. Lim, Early onset of reproductive function in
normal female mice treated with leptin, Science 275 (1997) 88–90.
[68] R.S. Ahima, J. Dushay, S.N. Flier, D. Prabakaran, J.S. Flier, Leptin accelerates the
onset of puberty in normal female mice, J. Clin. Invest. 99 (1997) 391–395.
[69] S. Yura, Y. Ogawa, N. Sagawa, H. Masuzaki, H. Itoh, K. Ebihara, M. Aizawa-Abe, S.Fujii, K. Nakao, Accelerated puberty and late-onset hypothalamic hypogonadism
in female transgenic skinnymice overexpressing leptin, J. Clin. Invest. 105 (2000)
749–755.
[70] I.A. Barash, C.C. Cheung, D.S. Weigle, H. Ren, E.B. Kabigting, J.L. Kuijper, D.K.
Clifton, R.A. Steiner, Leptin is a metabolic signal to the reproductive system,
Endocrinology 137 (1996) 3144–3147.
[71] N.M. Gruaz, M. Lalaoui, D.D. Pierroz, P. Englaro, P.C. Sizonenko, W.F. Blum, M.L.
Aubert, Chronic administration of leptin into the lateral ventricle induces sexual
maturation in severely food-restricted female rats, J. Neuroendocrinol. 10 (1998)
627–633.
[72] G.N. Wade, R.L. Lempicki, A.K. Panicker, R.M. Frisbee, J.D. Blaustein, Leptin
facilitates and inhibits sexual behavior in female hamsters, Am. J. Physiol. 272
(1997) R1354–R1358.
[73] P.D. Finn, M.J. Cunningham, K.Y. Pau, H.G. Spies, D.K. Clifton, R.A. Steiner, The
stimulatory effect of leptin on the neuroendocrine reproductive axis of the
monkey, Endocrinology 139 (1998) 4652–4662.
[74] B.A. Henry, J.W. Goding, A.J. Tilbrook, F.R. Dunshea, I.J. Clarke, Intracerebroven-
tricular infusion of leptin elevates the secretion of luteinising hormone without
affecting food intake in long-term food-restricted sheep, but increases growth
hormone irrespective of bodyweight, J. Endocrinol. 168 (2001) 67–77.
[75] S. Nagatani, P. Guthikonda, R.C. Thompson, H. Tsukamura, K.I. Maeda, D.L. Foster,
Evidence for GnRH regulation by leptin: leptin administration prevents reduced
pulsatile LH secretion during fasting, Neuroendocrinology 67 (1998) 370–376.
[76] M.L. Barker-Gibb, C.J. Scott, J.H. Boublik, I.J. Clarke, The role of neuropeptide Y
(NPY) in the control of LH secretion in the ewe with respect to season, NPY
receptor subtype and the site of action in the hypothalamus, J. Endocrinol. 147
(1995) 565–579.
[77] J.K. McDonald, M.D. Lumpkin, L.V. DePaolo, Neuropeptide-Y suppresses pulsatile
secretion of luteinizing hormone in ovariectomized rats: possible site of action,
Endocrinology 125 (1989) 186–191.
[78] C.D. Morrison, J.A. Daniel, J.H. Hampton, P.R. Buff, T.M. McShane, M.G. Thomas,
D.H. Keisler, Luteinizing hormone and growth hormone secretion in ewes infused
intracerebroventricularly with neuropeptide Y, Domest. Anim. Endocrinol. 24
(2003) 69–80.
[79] I.S. Farooqi, T. Wangensteen, S. Collins, W. Kimber, G. Matarese, J.M. Keogh, E.
Lank, B. Bottomley, J. Lopez-Fernandez, I. Ferraz-Amaro, M.T. Dattani, O. Ercan,
A.G. Myhre, L. Retterstol, R. Stanhope, J.A. Edge, S. McKenzie, N. Lessan, M.
Ghodsi, V. De Rosa, F. Perna, S. Fontana, I. Barroso, D.E. Undlien, S. O'Rahilly,
Clinical and molecular genetic spectrum of congenital deﬁciency of the leptin
receptor, N. Engl. J. Med. 356 (2007) 237–247.
[80] S.M. Bell, R.B. Stewart, S.C. Thompson, R.A. Meisch, Food-deprivation increases
cocaine-induced conditioned place preference and locomotor activity in rats,
Psychopharmacology (Berl.) 131 (1997) 1–8.
[81] K.D. Carr, Feeding, drug abuse, and the sensitization of reward bymetabolic need,
Neurochem. Res. 21 (1996) 1455–1467.
[82] D.P. Figlewicz, A. MacDonald Naleid, A.J. Sipols, Modulation of food reward by
adiposity signals, Physiol. Behav. 91 (2007) 473–478.
[83] D.P. Figlewicz, M.S. Higgins, S.B. Ng-Evans, P.J. Havel, Leptin reverses sucrose-
conditioned place preference in food-restricted rats, Physiol. Behav. 73 (2001)
229–234.
[84] S. Fulton, B. Woodside, P. Shizgal, Modulation of brain reward circuitry by leptin,
Science 287 (2000) 125–128.
[85] U. Shalev, J. Yap, Y. Shaham, Leptin attenuates acute food deprivation-induced
relapse to heroin seeking, J. Neurosci. 21 (2001) RC129.
[86] K.C. Berridge, T.E. Robinson, Parsing reward, Trends Neurosci 26 (2003) 507–513.
[87] K.C. Berridge, Food reward: brain substrates of wanting and liking, Neurosci.
Biobehav. Rev. 20 (1996) 1–25.
[88] C.M. Cannon, R.D. Palmiter, Reward without dopamine, J. Neurosci. 23 (2003)
10827–10831.
[89] S. Pecina, B. Cagniard, K.C. Berridge, J.W. Aldridge, X. Zhuang, Hyperdopaminergic
mutant mice have higher “wanting” but not “liking” for sweet rewards,
J. Neurosci. 23 (2003) 9395–9402.
[90] C.L. Wyvell, K.C. Berridge, Intra-accumbens amphetamine increases the condi-
tioned incentive salience of sucrose reward: enhancement of reward “wanting”
without enhanced “liking” or response reinforcement, J. Neurosci. 20 (2000)
8122–8130.
[91] D.P. Figlewicz, S.B. Evans, J. Murphy,M. Hoen, D.G. Baskin, Expression of receptors
for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of
the rat, Brain Res. 964 (2003) 107–115.
[92] S. Fulton, P. Pissios, R.P. Manchon, L. Stiles, L. Frank, E.N. Pothos, E. Maratos-Flier,
J.S. Flier, Leptin regulation of the mesoaccumbens dopamine pathway, Neuron 51
(2006) 811–822.
[93] J.D. Hommel, R. Trinko, R.M. Sears, D. Georgescu, Z.W. Liu, X.B. Gao, J.J. Thurmon,
M. Marinelli, R.J. DiLeone, Leptin receptor signaling in midbrain dopamine
neurons regulates feeding, Neuron 51 (2006) 801–810.
[94] T.V. Getchell, K. Kwong, C.P. Saunders, A.J. Stromberg, M.L. Getchell, Leptin
regulates olfactory-mediated behavior in ob/ob mice, Physiol. Behav. 87 (2006)
848–856.
[95] I.S. Farooqi, E. Bullmore, J. Keogh, J. Gillard, S. O'Rahilly, P.C. Fletcher, Leptin
regulates striatal regions and human eating behavior, Science 317 (2007) 1355.
[96] M. Rosenbaum, M. Sy, K. Pavlovich, R.L. Leibel, J. Hirsch, Leptin reverses weight
loss-induced changes in regional neural activity responses to visual food stimuli,
J. Clin. Invest. 118 (2008) 2583–2591.
[97] K. Baicy, E.D. London, J. Monterosso, M.L. Wong, T. Delibasi, A. Sharma, J. Licinio,
Leptin replacement alters brain response to food cues in genetically leptin-
deﬁcient adults, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18276–18279.
407C.D. Morrison / Biochimica et Biophysica Acta 1792 (2009) 401–408[98] M.E. Couce, B. Burguera, J.E. Parisi, M.D. Jensen, R.V. Lloyd, Localization of leptin
receptor in the human brain, Neuroendocrinology 66 (1997) 145–150.
[99] B. Burguera, M.E. Couce, J. Long, J. Lamsam, K. Laakso, M.D. Jensen, J.E. Parisi, R.V.
Lloyd, The long form of the leptin receptor (OB-Rb) is widely expressed in the
human brain, Neuroendocrinology 71 (2000) 187–195.
[100] X.F. Huang, I. Koutcherov, S. Lin, H.Q. Wang, L. Storlien, Localization of leptin
receptor mRNA expression in mouse brain, NeuroReport 7 (1996) 2635–2638.
[101] S. Shioda, H. Funahashi, S. Nakajo, T. Yada, O. Maruta, Y. Nakai, Immunohisto-
chemical localization of leptin receptor in the rat brain, Neurosci. Lett. 243
(1998) 41–44.
[102] E. Ur, D.A. Wilkinson, B.A. Morash, M. Wilkinson, Leptin immunoreactivity is
localized to neurons in rat brain, Neuroendocrinology 75 (2002) 264–272.
[103] B. Martin, M. Pearson, R. Brenneman, E. Golden, A. Keselman, T. Iyun, O.D.
Carlson, J.M. Egan, K.G. Becker, W. Wood 3rd., V. Prabhu, R. de Cabo, S. Maudsley,
M.P. Mattson, Conserved and differential effects of dietary energy intake on the
hippocampal transcriptomes of females and males, PLoS ONE 3 (2008) e2398.
[104] S.A. Farr, K.A. Yamada, D.A. Butterﬁeld, H.M. Abdul, L. Xu, N.E. Miller, W.A. Banks,
J.E. Morley, Obesity and hypertriglyceridemia produce cognitive impairment,
Endocrinology 149 (2008) 2628–2636.
[105] J. Harvey, Leptin regulation of neuronal excitability and cognitive function, Curr.
Opin. Pharmacol. 7 (2007) 643–647.
[106] X.L. Li, S. Aou, Y. Oomura, N. Hori, K. Fukunaga, T. Hori, Impairment of long-term
potentiation and spatial memory in leptin receptor-deﬁcient rodents,
Neuroscience 113 (2002) 607–615.
[107] Y. Oomura, N. Hori, T. Shiraishi, K. Fukunaga, H. Takeda, M. Tsuji, T. Matsumiya, M.
Ishibashi, S. Aou, X.L. Li, D. Kohno, K. Uramura, H. Sougawa, T. Yada, M.J. Wayner,
K. Sasaki, Leptin facilitates learning and memory performance and enhances
hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats,
Peptides 27 (2006) 2738–2749.
[108] L.J. Shanley, A.J. Irving, J. Harvey, Leptin enhances NMDA receptor function and
modulates hippocampal synaptic plasticity, J. Neurosci. 21 (2001) RC186.
[109] M. Durakoglugil, A.J. Irving, J. Harvey, Leptin induces a novel form of NMDA
receptor-dependent long-term depression, J. Neurochem. 95 (2005) 396–405.
[110] C.D. Walker, H. Long, S. Williams, D. Richard, Long-lasting effects of elevated
neonatal leptin on rat hippocampal function, synaptic proteins and NMDA
receptor subunits, J. Neurosci. Res. 85 (2007) 816–828.
[111] L.J. Shanley, A.J. Irving, M.G. Rae, M.L. Ashford, J. Harvey, Leptin inhibits rat
hippocampal neurons via activation of large conductance calcium-activated K+
channels, Nat. Neurosci. 5 (2002) 299–300.
[112] D. O'Malley, A.J. Irving, J. Harvey, Leptin-induced dynamic alterations in the actin
cytoskeleton mediate the activation and synaptic clustering of BK channels,
FASEB J. 19 (2005) 1917–1919.
[113] A.J. Irving, L.Wallace, D.Durakoglugil, J. Harvey, Leptin enhancesNR2B-mediatedN-
methyl-D-aspartate responses via a mitogen-activated protein kinase-dependent
process in cerebellar granule cells, Neuroscience 138 (2006) 1137–1148.
[114] R.S. Ahima, C. Bjorbaek, S. Osei, J.S. Flier, Regulation of neuronal and glial proteins by
leptin: implications for brain development, Endocrinology 140 (1999) 2755–2762.
[115] C.M. Steppan, A.G. Swick, A role for leptin in brain development, Biochem.
Biophys. Res. Commun. 256 (1999) 600–602.
[116] J. Udagawa, R. Hashimoto, H. Suzuki, T. Hatta, Y. Sotomaru, K. Hioki, Y. Kagohashi,
T. Nomura, Y. Minami, H. Otani, The role of leptin in the development of the
cerebral cortex in mouse embryos, Endocrinology 147 (2006) 647–658.
[117] J. Udagawa, M. Nimura, Y. Kagohashi, H. Otani, Leptin deﬁciency causes pycnotic
change in fetal cingulate cortical cells, Congenit. Anom. (Kyoto) 46 (2006) 16–20.
[118] J. Udagawa, T. Hatta, R. Hashimoto, H. Otani, Roles of leptin in prenatal and
perinatal brain development, Congenit. Anom. (Kyoto) 47 (2007) 77–83.
[119] N. Pannacciulli, D.S. Le, K. Chen, E.M. Reiman, J. Krakoff, Relationships between
plasma leptin concentrations and human brain structure: a voxel-based
morphometric study, Neurosci. Lett. 412 (2007) 248–253.
[120] J.A. Matochik, E.D. London, B.O. Yildiz, M. Ozata, S. Caglayan, A.M. DePaoli, M.L.
Wong, J. Licinio, Effect of leptin replacement on brain structure in genetically
leptin-deﬁcient adults, J. Clin. Endocrinol. Metab. 90 (2005) 2851–2854.
[121] S.G. Bouret, S.J. Draper, R.B. Simerly, Trophic action of leptin on hypothalamic
neurons that regulate feeding, Science 304 (2004) 108–110.
[122] C.E. Oldreive, J. Harvey, G.H. Doherty, Neurotrophic effects of leptin on cerebellar
Purkinje but not granule neurons in vitro, Neurosci. Lett. 438 (2008) 17–21.
[123] D. O'Malley, N. MacDonald, S. Mizielinska, C.N. Connolly, A.J. Irving, J. Harvey,
Leptin promotes rapid dynamic changes in hippocampal dendritic morphology,
Mol. Cell. Neurosci. 35 (2007) 559–572.
[124] A. Valerio, V. Ghisi, M. Dossena, C. Tonello, A. Giordano, A. Frontini, M. Ferrario,
M. Pizzi, P. Spano, M.O. Carruba, E. Nisoli, Leptin increases axonal growth cone
size in developing mouse cortical neurons by convergent signals inactivating
glycogen synthase kinase-3beta, J. Biol. Chem. 281 (2006) 12950–12958.
[125] S. Pinto, A.G. Roseberry, H. Liu, S. Diano, M. Shanabrough, X. Cai, J.M. Friedman,
T.L. Horvath, Rapid rewiring of arcuate nucleus feeding circuits by leptin, Science
304 (2004) 110–115.
[126] A.P. Signore, F. Zhang, Z. Weng, Y. Gao, J. Chen, Leptin neuroprotection in the CNS:
mechanisms and therapeutic potentials, J. Neurochem. 106 (2008) 1977–1990.
[127] B.L. Tang, Leptin as a neuroprotective agent, Biochem. Biophys. Res. Commun.
368 (2008) 181–185.
[128] Y. Fujita, M. Murakami, Y. Ogawa, H. Masuzaki, M. Tanaka, S. Ozaki, K. Nakao, T.
Mimori, Leptin inhibits stress-induced apoptosis of T lymphocytes, Clin. Exp.
Immunol. 128 (2002) 21–26.
[129] M.R. Hoda, S.J. Keely, L.S. Bertelsen, W.G. Junger, D. Dharmasena, K.E. Barrett,
Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells, Br. J.
Surg. 94 (2007) 346–354.[130] J.K. Howard, G.M. Lord, G. Matarese, S. Vendetti, M.A. Ghatei, M.A. Ritter, R.I.
Lechler, S.R. Bloom, Leptin protects mice from starvation-induced lymphoid
atrophy and increases thymic cellularity in ob/ob mice, J. Clin. Invest. 104 (1999)
1051–1059.
[131] M. Shimabukuro, M.Y. Wang, Y.T. Zhou, C.B. Newgard, R.H. Unger, Protection
against lipoapoptosis of beta cells through leptin-dependent maintenance of
Bcl-2 expression, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9558–9561.
[132] P. Somasundar, A.K. Yu, L. Vona-Davis, D.W. McFadden, Differential effects of
leptin on cancer in vitro, J. Surg. Res. 113 (2003) 50–55.
[133] Z. Guo, H. Jiang, X. Xu, W. Duan, M.P. Mattson, Leptin-mediated cell survival
signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial
stabilization, J. Biol. Chem. 283 (2008) 1754–1763.
[134] V.C. Russo, S. Metaxas, K. Kobayashi, M. Harris, G.A. Werther, Antiapoptotic
effects of leptin in human neuroblastoma cells, Endocrinology 145 (2004)
4103–4112.
[135] F. Zhang, S. Wang, A.P. Signore, J. Chen, Neuroprotective effects of leptin against
ischemic injury induced by oxygen-glucose deprivation and transient cerebral
ischemia, Stroke 38 (2007) 2329–2336.
[136] F. Zhang, J. Chen, Leptin protects hippocampal CA1 neurons against ischemic
injury, J. Neurochem. 107 (2008) 578–587.
[137] E. Dicou, S. Attoub, P. Gressens, Neuroprotective effects of leptin in vivo and in
vitro, NeuroReport 12 (2001) 3947–3951.
[138] J.C. Garza, M. Guo, W. Zhang, X.Y. Lu, Leptin increases adult hippocampal
neurogenesis in vivo and in vitro, J. Biol. Chem. 283 (2008) 18238–18247.
[139] Z. Weng, A.P. Signore, Y. Gao, S. Wang, F. Zhang, T. Hastings, X.M. Yin, J. Chen,
Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death
via mitogen-activated protein kinase signaling, J. Biol. Chem. 282 (2007)
34479–34491.
[140] A. Valerio, M. Dossena, P. Bertolotti, F. Boroni, I. Sarnico, G. Faraco, A. Chiarugi, A.
Frontini, A. Giordano, H.C. Liou, M.G. De Simoni, P. Spano, M.O. Carruba, M. Pizzi,
E. Nisoli, Leptin is induced in the ischemic cerebral cortex and exerts
neuroprotection through NF-{kappa}B/c-Rel-dependent transcription, Stroke
(in press) [PMID:19023096].
[141] L. Xu, N. Rensing, X.F. Yang, H.X. Zhang, L.L. Thio, S.M. Rothman, A.E. Weisenfeld,
M. Wong, K.A. Yamada, Leptin inhibits 4-aminopyridine- and pentylenetetra-
zole-induced seizures and AMPAR-mediated synaptic transmission in rodents,
J. Clin. Invest. 118 (2008) 272–280.
[142] J. Gunstad, M.B. Spitznagel, T.A. Keary, E. Glickman, T. Alexander, J. Karrer, K.
Stanek, L. Reese, J. Juvancic-Heltzel, Serum leptin levels are associated with
cognitive function in older adults, Brain Res. 1230 (2008) 233–236.
[143] K.F. Holden, K. Lindquist, F.A. Tylavsky, C. Rosano, T.B. Harris, K. Yaffe, Serum
leptin level and cognition in the elderly: ﬁndings from the health ABC study,
Neurobiol. Aging (in press) [PMID:18358569].
[144] J.S. Huang, S. Letendre, J.Marquie-Beck,M. Cherner, J.A.McCutchan, I. Grant, R. Ellis,
Low CSF leptin levels are associatedwithworse learning andmemory performance
in HIV-infected men, J. Neuroimmune Pharmacol. 2 (2007) 352–358.
[145] G.J. Paz-Filho, T. Babikian, R. Asarnow, K. Esposito, H.K. Erol, M.L. Wong, J. Licinio,
Leptin replacement improves cognitive development, PLoS ONE 3 (2008) e3098.
[146] R. Ohta, N. Shigemura, K. Sasamoto, K. Koyano, Y. Ninomiya, Conditioned taste
aversion learning in leptin-receptor-deﬁcient db/db mice, Neurobiol. Learn.
Mem. 80 (2003) 105–112.
[147] G. Winocur, C.E. Greenwood, G.G. Piroli, C.A. Grillo, L.R. Reznikov, L.P. Reagan, B.S.
McEwen, Memory impairment in obese Zucker rats: an investigation of cognitive
function in an animal model of insulin resistance and obesity, Behav. Neurosci.
119 (2005) 1389–1395.
[148] S.A. Farr, W.A. Banks, J.E. Morley, Effects of leptin on memory processing,
Peptides 27 (2006) 1420–1425.
[149] K. Paulus, C. Schulz, H. Lehnert, Central nervous effects of leptin and insulin on
hippocampal leptin and insulin receptor expression following a learning task in
Wistar rats, Neuropsychobiology 51 (2005) 100–106.
[150] K. El-Haschimi, D.D. Pierroz, S.M. Hileman, C. Bjorbaek, J.S. Flier, Two defects
contribute to hypothalamic leptin resistance in mice with diet-induced obesity,
J. Clin. Invest. 105 (2000) 1827–1832.
[151] W.A. Banks, C.L. Farrell, Impaired transport of leptin across the blood-brain
barrier in obesity is acquired and reversible, Am. J. Physiol. Endocrinol. Metab.
285 (2003) E10–E15.
[152] M.G. Myers, M.A. Cowley, H. Munzberg, Mechanisms of leptin action and leptin
resistance, Annu. Rev. Physiol. 70 (2008) 537–556.
[153] S.R. Ladyman, Leptin resistance during pregnancy in the rat, J. Neuroendocrinol.
20 (2008) 269–277.
[154] C.D. Morrison, Leptin resistance and the response to positive energy balance,
Physiol. Behav. 94 (2008) 660–663.
[155] P.J. Scarpace, Y. Zhang, Elevated leptin: consequence or cause of obesity? Front.
Biosci. 12 (2007) 3531–3544.
[156] P.J. Scarpace, M. Matheny, N. Tumer, Hypothalamic leptin resistance is associated
with impaired leptin signal transduction in aged obese rats, Neuroscience 104
(2001) 1111–1117.
[157] R. Pal, A. Sahu, Leptin signaling in the hypothalamus during chronic central leptin
infusion, Endocrinology 144 (2003) 3789–3798.
[158] E. Krol, J.S. Duncan, P. Redman, P.J. Morgan, J.G. Mercer, J.R. Speakman,
Photoperiod regulates leptin sensitivity in ﬁeld voles, Microtus agrestis, J. Comp.
Physiol. B 176 (2006) 153–163.
[159] E. Krol, A. Tups, Z.A. Archer, A.W. Ross, K.M. Moar, L.M. Bell, J.S. Duncan, C. Mayer,
P.J. Morgan, J.G. Mercer, J.R. Speakman, Altered expression of SOCS3 in the
hypothalamic arcuate nucleus during seasonal body mass changes in the ﬁeld
vole, Microtus agrestis, J. Neuroendocrinol. 19 (2007) 83–94.
408 C.D. Morrison / Biochimica et Biophysica Acta 1792 (2009) 401–408[160] C.L. White, A. Whittington, M.J. Barnes, Z.Q.Wang, G. Bray, C.D. Morrison, HF diets
increase hypothalamic PTP1B and induce leptin resistance through both leptin-
dependent and independent mechanisms, Am. J. Physiol. Endocrinol. Metab. (in
press) [PMID:19017730].
[161] C.D. Morrison, C.L. White, Z. Wang, S.Y. Lee, D.S. Lawrence, W.T. Cefalu, Z.Y. Zhang,
T.W. Gettys, Increased hypothalamic protein tyrosine phosphatase 1B contri-
butes to leptin resistance with age, Endocrinology 148 (2007) 433–440.
[162] H. Munzberg, J.S. Flier, C. Bjorbaek, Region-speciﬁc leptin resistance within the
hypothalamus of diet-induced obese mice, Endocrinology 145 (2004) 4880–4889.
[163] S.R. Ladyman, D.R. Grattan, Region-speciﬁc reduction in leptin-induced phos-
phorylation of signal transducer and activator of transcription-3 (STAT3) in the
rat hypothalamus is associated with leptin resistance during pregnancy,
Endocrinology 145 (2004) 3704–3711.[164] K. Rahmouni, D.A. Morgan, G.M. Morgan, A.L. Mark, W.G. Haynes, Role of
selective leptin resistance in diet-induced obesity hypertension, Diabetes 54
(2005) 2012–2018.
[165] V. Prpic, P.M. Watson, I.C. Frampton, M.A. Sabol, G.E. Jezek, T.W. Gettys,
Differential mechanisms and development of leptin resistance in A/J versus
C57BL/6J mice during diet-induced obesity, Endocrinology 144 (2003)
1155–1163.
[166] P. Harle, R.H. Straub, Leptin is a link between adipose tissue and inﬂammation,
Ann. N.Y. Acad. Sci. 1069 (2006) 454–462.
[167] G. Matarese, S. Moschos, C.S. Mantzoros, Leptin in immunology, J. Immunol. 174
(2005) 3137–3142.
[168] G. Karsenty, Convergence between bone and energy homeostases: leptin
regulation of bone mass, Cell Metab. 4 (2006) 341–348.
